4//SEC Filing
Schwartz Jonathan David 4
Accession 0001140361-25-020162
CIK 0001281895other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 4:05 PM ET
Size
4.9 KB
Accession
0001140361-25-020162
Insider Transaction Report
Form 4
Schwartz Jonathan David
See Remarks
Transactions
- Sale
Common Stock
2025-05-20$6.45/sh−801$5,163→ 235,255 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001726398
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 4:05 PM ET
- Size
- 4.9 KB